<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yi E</submitter><funding>National Basic Research Program of China</funding><funding>National Natural Science Foundation of China</funding><pagination>e479</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8288003</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(7)</volume><pubmed_abstract>Chronic obstructive pulmonary disease is a complex condition with multiple etiologies, including inflammation. We identified a novel long noncoding RNA (lncRNA), interleukin 6 antisense RNA 1 (IL6-AS1), which is upregulated in this disease and is associated with airway inflammation. We found that IL6-AS1 promotes the expression of inflammatory factors, especially interleukin (IL) 6. Mechanistically, cytoplasmic IL6-AS1 acts as an endogenous sponge by competitively binding to the microRNA miR-149-5p to stabilize IL-6 mRNA. Nuclear IL6-AS1 promotes IL-6 transcription by recruiting early B-cell factor 1 to the IL-6 promoter, which increases the methylation of the H3K4 histone and acetylation of the H3K27 histone. We propose a model of lncRNA expression in both the nucleus and cytoplasm that e</pubmed_abstract><journal>Clinical and translational medicine</journal><pubmed_title>Long noncoding RNA IL6-AS1 is highly expressed in chronic obstructive pulmonary disease and is associated with interleukin 6 by targeting miR-149-5p and early B-cell factor 1.</pubmed_title><pmcid>PMC8288003</pmcid><funding_grant_id>81670040</funding_grant_id><funding_grant_id>2016YFC1304101</funding_grant_id><funding_grant_id>81970045</funding_grant_id><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Pu J</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Huang P</pubmed_authors><pubmed_authors>Liang C</pubmed_authors><pubmed_authors>Lin B</pubmed_authors><pubmed_authors>Zheng M</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Hong W</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Hao B</pubmed_authors><pubmed_authors>Ran P</pubmed_authors><pubmed_authors>Yi E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long noncoding RNA IL6-AS1 is highly expressed in chronic obstructive pulmonary disease and is associated with interleukin 6 by targeting miR-149-5p and early B-cell factor 1.</name><description>Chronic obstructive pulmonary disease is a complex condition with multiple etiologies, including inflammation. We identified a novel long noncoding RNA (lncRNA), interleukin 6 antisense RNA 1 (IL6-AS1), which is upregulated in this disease and is associated with airway inflammation. We found that IL6-AS1 promotes the expression of inflammatory factors, especially interleukin (IL) 6. Mechanistically, cytoplasmic IL6-AS1 acts as an endogenous sponge by competitively binding to the microRNA miR-149-5p to stabilize IL-6 mRNA. Nuclear IL6-AS1 promotes IL-6 transcription by recruiting early B-cell factor 1 to the IL-6 promoter, which increases the methylation of the H3K4 histone and acetylation of the H3K27 histone. We propose a model of lncRNA expression in both the nucleus and cytoplasm that e</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2026-05-08T21:50:14.306Z</modification><creation>2022-02-11T01:27:36.307Z</creation></dates><accession>S-EPMC8288003</accession><cross_references><pubmed>34323408</pubmed><doi>10.1002/ctm2.479</doi></cross_references></HashMap>